Clinical trial
Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line
NCT00116467 is registered in ClinicalTrials.gov with Cell Genesys as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Vaccination in the Peripheral Stem Cell Transplant Setting for Acute Myelogenous Leukemia: The Use of Autologous Tumor Cells With an Allogeneic GM-CSF Producing Cell Line
- Lead sponsor
- Cell Genesys
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- March 31, 2001
- Completion date
- January 31, 2006
- Enrollment
- 55
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
acute myelogenous leukemia